{"name":"Iroko Pharmaceuticals, LLC","slug":"iroko-pharmaceuticals-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Diclofenac Capsules high dose","genericName":"Diclofenac Capsules high dose","slug":"diclofenac-capsules-high-dose","indication":"Osteoarthritis","status":"phase_2"},{"name":"Diclofenac Capsules low dose","genericName":"Diclofenac Capsules low dose","slug":"diclofenac-capsules-low-dose","indication":"Osteoarthritis","status":"phase_2"},{"name":"Diclofenac Test (lower dose)","genericName":"Diclofenac Test (lower dose)","slug":"diclofenac-test-lower-dose","indication":"Acute pain management (Phase 3 evaluation at lower dose)","status":"phase_3"},{"name":"Diclofenac Test (upper dose)","genericName":"Diclofenac Test (upper dose)","slug":"diclofenac-test-upper-dose","indication":"Acute pain management (Phase 3 trial indication for upper dose formulation)","status":"phase_3"},{"name":"Indomethacin Capsules high dose","genericName":"Indomethacin Capsules high dose","slug":"indomethacin-capsules-high-dose","indication":"Osteoarthritis","status":"phase_2"}]}],"pipeline":[{"name":"Diclofenac Capsules high dose","genericName":"Diclofenac Capsules high dose","slug":"diclofenac-capsules-high-dose","phase":"phase_2","mechanism":"Diclofenac works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the production of prostaglandins, leading to reduced inflammation and pain.","indications":["Osteoarthritis","Rheumatoid arthritis","Ankylosing spondylitis"],"catalyst":""},{"name":"Diclofenac Capsules low dose","genericName":"Diclofenac Capsules low dose","slug":"diclofenac-capsules-low-dose","phase":"phase_2","mechanism":"Diclofenac works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the production of prostaglandins, leading to reduced inflammation and pain.","indications":["Osteoarthritis","Rheumatoid arthritis","Ankylosing spondylitis"],"catalyst":""},{"name":"Diclofenac Test (lower dose)","genericName":"Diclofenac Test (lower dose)","slug":"diclofenac-test-lower-dose","phase":"phase_3","mechanism":"Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and decrease inflammation and pain.","indications":["Acute pain management (Phase 3 evaluation at lower dose)","Osteoarthritis or rheumatoid arthritis (potential indication)"],"catalyst":""},{"name":"Diclofenac Test (upper dose)","genericName":"Diclofenac Test (upper dose)","slug":"diclofenac-test-upper-dose","phase":"phase_3","mechanism":"Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and decrease inflammation and pain.","indications":["Acute pain management (Phase 3 trial indication for upper dose formulation)","Chronic inflammatory conditions such as osteoarthritis or rheumatoid arthritis"],"catalyst":""},{"name":"Indomethacin Capsules high dose","genericName":"Indomethacin Capsules high dose","slug":"indomethacin-capsules-high-dose","phase":"phase_2","mechanism":"Non-selective COX-1 and COX-2 inhibitor","indications":["Osteoarthritis","Rheumatoid arthritis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPNFR3LWhyVmdSR1Z6bnpibWZORERnX1NhM2hTMTk1YTFXd255UjRpZVJpdUZSR2l4b09ZMEpwT1pwMXdBRk9iQmFiLS1qcVhJZkZMV3NhT3cxUmNPZUxZMGV1eXkwdU9yU0JreHZzc0dlNFhkcVBoU0xJcmhyVE9IUlhWemhjUGFqeWZScl9XLW54VnExOFZlRTV6UEthcUNxTzlnTG5ydGQ2QQ?oc=5","date":"2026-02-08","type":"regulatory","source":"lupin.com","summary":"Lupin Receives Tentative Approval for Generic Zorvolex® Capsules - Lupin | Press Release - lupin.com","headline":"Lupin Receives Tentative Approval for Generic Zorvolex® Capsules - Lupin | Press Release","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPNEx3eVdsSzFHVi1MSUxRenZ3TnlNbHBoSVhmVFBEYnJ3V3FIX1d5TlFFNnRqSnJWZTUxc1A1V3hyQnFIYUxfcXRxMHQ1b2x4bHpNWVRGTjNwci1SQ2FLZlVpQUowdHptTkVIQnpqdTNVWk95ck45aUdfRlBYdUo1d1ozQWxEajB5RGxoTWxnNkl5Y0VGZlBYYXMzeERSR1JVZ1B3dkVOREk2TXVNWWxMTFc4RW9iWkNwVWVIYWVrY0VCX2htU3NreHFGS3NvVFRBTk52TnZQTFFYVTlyYW1kaHRteWIyQTl1ZEpMc24yRkstUktTdUg5YzVXdFlVeldVMXFMY1NOZ1o?oc=5","date":"2025-09-16","type":"trial","source":"GlobeNewswire","summary":"Gout Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in Gout Therapeutics | DelveInsight - GlobeNewswire","headline":"Gout Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in Gout Therapeutics | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPRUQ0WGlqalRMWm9vU0NSbFlwQ0tvcm1YNk95TzZXWEt1WXBBVUoxTGozeUFMc3FuVmV1V0pxOTl5cGtjVkFKQzRsMUxfcGxOVkNFWHd5dVNpcjhaQllZckV0UGJGbVpBWmltV0dRRVlIZnR0emtDTVFYcUQ1QkdsdkMwcnNIc09wN1pGU1dsSVlnb2VE?oc=5","date":"2019-02-15","type":"deal","source":"Fierce Pharma","summary":"Egalet's 70% price increase shows the buy-and-hike strategy is alive and well - Fierce Pharma","headline":"Egalet's 70% price increase shows the buy-and-hike strategy is alive and well","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxOTndRZkJESEs3dVNaOEtWRmUtSzcxR1l4SWFiWTNVZDFhZ3dYU0hrUUQ4YnVvU0RXdnV0cTZ4M2ZheEtVNkVOWUJKRXRVUUphSG4yWlEzTl9KdS1TcW1neW5Zc3FyNWxlZXU1RVl3Mk1kTkJjWHhhMlRXVjFJZEN5ZzRHUWZ2VzRFVWJCUFRSR0ZKcDVNZFdDUldMNHByUWJ4Q05ubndObFFWTlpJSkI3Q2dYeGFMbXBhWndJRk1ydW1oMzlVc3B4U2MxX2w?oc=5","date":"2018-04-11","type":"pipeline","source":"Wealth Professional Canada","summary":"Price-markup schemes linked to arrival of 'pharma bros' - Wealth Professional Canada","headline":"Price-markup schemes linked to arrival of 'pharma bros'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPNzRvaXNXQXR6NXJ6UHNuQTN0TE0zZldNXzZxeFloTTFnNXBPcklyajY0NTM0OWJIZS10TDctbksxX19YVjBnZy10M2J3eGMxNUxENmRqLUlEZWdWcEowUG1QaG5zMlNMdkxZaExwcnlrZUhfMXUzTDNIc2pGem9sYV9OYWg5LWpwOXd6TjZxR2JDdVo1bzRNUFdQOV9id3RqU3RlM3M1V3UwZVZkRkZOZVFTYXUyX2tjakpNUHA0RzhGeWRTLTZV?oc=5","date":"2018-04-06","type":"pipeline","source":"Bloomberg.com","summary":"These New Pharma Bros Are Wreaking Havoc on Prescription Drug Prices - Bloomberg.com","headline":"These New Pharma Bros Are Wreaking Havoc on Prescription Drug Prices","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOeldJTGRQX1hXaDlDSkpPUWoyamdsUlNNdTFTRkw2MFdUR1FqOWFvNnduZVdWU0ZTVjgxTVlmemFIT0hHZ0p6UWdQcUkyRDlVTi1fdmd3cFlMaGtNeVczWnNPSFgtdjlUN1V6WGpJMjUxYVZDazk5dk51V2t1YVYxYmRWbHoyVTNBZzRadTIxN1UyX1lBR0lETEJGSEl6WDEzWnhmUjFpYXN1VjlyWWZ3QlVZT2tzQjEzNy1HamZOV05FT3M?oc=5","date":"2017-06-01","type":"pipeline","source":"Inquirer.com","summary":"Iroko Pharmaceuticals lays off 122 full- and part-time employees - Inquirer.com","headline":"Iroko Pharmaceuticals lays off 122 full- and part-time employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNV213TUdQOEVlOUVUc3NlSmNpbV9nWTBnUnlxOWJvdzM4ckpZS1AyRVFhMEMzcWMzbDZ4YzcwTVNIX1BvVkhHRnRRdWpGb2FsLXk3cFpURVNqZ19qZXdmMWpJVU1JSmdJN2RwWkxHZlhyb3hZOEIyR1NnNzR0SHNwNXh0VUZhY1o1S2tndGZZWDlrR1ZERXlibTlfWGxkUWw1MHRZMjdVUnFjTksyZzZfWg?oc=5","date":"2017-01-06","type":"patent","source":"PR Newswire","summary":"Iroko Pharmaceuticals Announces Key Patent for VIVLODEX® - PR Newswire","headline":"Iroko Pharmaceuticals Announces Key Patent for VIVLODEX®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQTGVjNVFTRll1bjN3Tk9LRldqQ0ZhWFZGTlNpVHViSkM1alpoa29zN0ZhXzJ5eHo3YzhqU081UnNxclZfUlY5cHdaUklGWFc0Ukxsa18tZkRqWFA2aTBZVkZNOVNRMnNmdjVPbGtKWUZlNGFha1B5dS1rMW1QZXFpYTc1VWxLSVQ0eDB6UDZJbkhWX2FaRDVSRDVNNDM3eGE1cjhTS2tLcmZrMTU4NmRqRXpldXZEYXpGSTl0anBpcjhVLUk3N2Y4T3dRM19nNjRXWmc?oc=5","date":"2016-07-18","type":"pipeline","source":"Inquirer.com","summary":"Business People on the Move: Vanguard hires general counsel and managing director - Inquirer.com","headline":"Business People on the Move: Vanguard hires general counsel and managing director","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1nVC1RMVJFUE5aZVpJNmRuZ1RUYWhENlp6NzVZUW9NT1A1S3k3blNWZE5RM1g2akxGY1c1YU9aNHFsYmlBNnFiMnZlZ3VlX0JHQXdKMkVTaE1YampaVVRGc3pjeWxvOFpkTVo4eHM1TWhyUWpL?oc=5","date":"2015-10-23","type":"regulatory","source":"MultiVu","summary":"Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX - MultiVu","headline":"Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOYmM2RFNWZ0JReVRKdXFXTlcyc2hhWWZCS1JFRVlnSmVhd0NIeW5DVXJmUXhvMkpkREg1SVp3YzFuUnY4cTBXXzVBQ0tqcnZzNlB3MDVYbUEzUk1RQ2FiUmhHN2o3Z0lMUHZDcmRWblk1QWwtMi1yWS1zSERpWFhud3N3dk5Da0lWTGNiTGlqSDRfWC1FeFV2a2VoX3JlZmNFd2k2bVRucDRZZ1pyQmRkNw?oc=5","date":"2013-01-02","type":"earnings","source":"Pharmaceutical Technology","summary":"Iroko Pharmaceuticals Global Headquarters, Philadelphia - Pharmaceutical Technology","headline":"Iroko Pharmaceuticals Global Headquarters, Philadelphia","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_2":3,"phase_3":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}